Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: The Challenge That Lies Ahead | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: The Challenge That Lies Ahead

Acta Haematol (2016) 136 (1): 43–44.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Using a treatment diary to improve the medication adherence in patients with chronic myeloid leukaemia

Fiorenzo Santoleri
Ruggero Lasala
Andrea Logreco
Elena Ranucci
Alberto Costantini

Journal of Oncology Pharmacy Practice (2019) 25 (5): 1035.

Use and costs of originator and biosimilar erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia: real-world evidence from an Italian hospital

Fiorenzo Santoleri
Alessia Romagnoli
Alberto Costantini

Future Oncology (2019) 15 (1): 45.

Treatment strategies for adolescent and young adult patients with acute myeloid leukemia

Kristen O’Dwyer
David R. Freyer
John T. Horan

Blood (2018) 132 (4): 362.